Canoo saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Canoo’s patent filings and grants. Buy the databook here.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Canoo has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Canoo is filings its patents. Among the top granted patent authorities, Canoo has 100% of its grants in United States(US).
Porsche Automobil Holding and Hyundai Motor could be the strongest competitors for Canoo
Patents related to autonomous vehicles and climate change lead Canoo's portfolio
Canoo has the highest number of patents in autonomous vehicles followed by, climate change and emissions reduction. For autonomous vehicles, nearly 25% of patents were filed and no patents were granted in Q2 2024.
Controls and modules related patents lead Canoo portfolio followed by electrical products, and active and passive safety
Canoo has highest number of patents in controls and modules followed by electrical products, active and passive safety, electrification technologies, and electrified vehicles. For controls and modules, nearly 29% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Canoo's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.